N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis

Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers

(2016) Brett A. Clementz et al.   AMERICAN JOURNAL OF PSYCHIATRY

Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis

(2016) Giles E. Hardingham et al.   NATURE REVIEWS NEUROSCIENCE

Genetic Polymorphism Associated Prefrontal Glutathione and Its Coupling With Brain Glutamate and Peripheral Redox Status in Early Psychosis

(2016) Lijing Xin et al.   SCHIZOPHRENIA BULLETIN

Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology?

(2016) P. Steullet et al.   SCHIZOPHRENIA RESEARCH

Prescription Practices in the Treatment of First-Episode Schizophrenia Spectrum Disorders: Data From the National RAISE-ETP Study

(2015) Delbert G. Robinson et al.   AMERICAN JOURNAL OF PSYCHIATRY

Pharmacological treatment of negative symptoms in schizophrenia

(2015) Hans-Jürgen Möller et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Schizophrenia drug discovery and development in an evolving era: Are new drug targets fulfilling expectations?

(2015) John Dunlop et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Molecular substrates of schizophrenia: homeostatic signaling to connectivity

(2015) M A Landek-Salgado et al.   MOLECULAR PSYCHIATRY

Juvenile Antioxidant Treatment Prevents Adult Deficits in a Developmental Model of Schizophrenia

(2014) Jan-Harry Cabungcal et al.   NEURON

Is Prophylactic Psychiatry around the Corner? Combating Adolescent Oxidative Stress for Adult Psychosis and Schizophrenia

(2014) Akira Sawa et al.   NEURON

Meta-Analysis of Oxidative Stress in Schizophrenia

(2013) Joshua Flatow et al.   BIOLOGICAL PSYCHIATRY

N-acetylcysteine Boosts Brain and Blood Glutathione in Gaucher and Parkinson Diseases

(2013) Mary J. Holmay et al.   CLINICAL NEUROPHARMACOLOGY

N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia

(2013) Mehdi Farokhnia et al.   CLINICAL NEUROPHARMACOLOGY

Treatment and Early Intervention in Psychosis Program (TIPP-Lausanne): implementation of an early intervention programme for psychosis in Switzerland

(2013) Philipp Sebastian Baumann et al.   Early Intervention in Psychiatry

N-Acetylcysteine amide: a derivative to fulfill the promises of N-Acetylcysteine

(2013) K. Sunitha et al.   FREE RADICAL RESEARCH

Perineuronal nets protect fast-spiking interneurons against oxidative stress

(2013) J.-H. Cabungcal et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

N-Acetylcysteine for the Treatment of Glutathione Deficiency and Oxidative Stress in Schizophrenia

(2012) Dikoma C. Shungu   BIOLOGICAL PSYCHIATRY

Neurocognition in the Psychosis Risk Syndrome: A Quantitative and Qualitative Review

(2012) Anthony J. Giuliano et al.   CURRENT PHARMACEUTICAL DESIGN

Cortical interneurons, immune factors and oxidative stress as early targets for schizophrenia

(2012) Patricio O’Donnell   EUROPEAN JOURNAL OF NEUROSCIENCE

Marked reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with recent-onset schizophrenia

(2012) J M Coughlin et al.   MOLECULAR PSYCHIATRY

Glutathione Precursor N-Acetyl-Cysteine Modulates EEG Synchronization in Schizophrenia Patients: A Double-Blind, Randomized, Placebo-Controlled Trial

(2012) Cristian Carmeli et al.   PLoS One

N-Acetylcysteine Normalizes Neurochemical Changes in the Glutathione-Deficient Schizophrenia Mouse Model During Development

(2011) Joao Miguel das Neves Duarte et al.   BIOLOGICAL PSYCHIATRY

International Consensus Study of Antipsychotic Dosing

(2010) David M. Gardner et al.   AMERICAN JOURNAL OF PSYCHIATRY

Genetic Dysregulation of Glutathione Synthesis Predicts Alteration of Plasma Thiol Redox Status in Schizophrenia

(2010) René Gysin et al.   ANTIOXIDANTS & REDOX SIGNALING

The Role of Energy Metabolism Dysfunction and Oxidative Stress in Schizophrenia Revealed by Proteomics

(2010) Daniel Martins-de-Souza et al.   ANTIOXIDANTS & REDOX SIGNALING

Magnetic Resonance Spectroscopy Study of the Antioxidant Defense System in Schizophrenia

(2010) Daisuke Matsuzawa et al.   ANTIOXIDANTS & REDOX SIGNALING

Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View

(2010) Jeffrey K. Yao et al.   ANTIOXIDANTS & REDOX SIGNALING

Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders

(2010) Jeremy W. Gawryluk et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Antipsychotic Dose Equivalents and Dose-Years: A Standardized Method for Comparing Exposure to Different Drugs

(2009) Nancy C. Andreasen et al.   BIOLOGICAL PSYCHIATRY

Redox dysregulation, neurodevelopment, and schizophrenia

(2009) Kim Q Do et al.   CURRENT OPINION IN NEUROBIOLOGY

MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T

(2009) Ralf Mekle et al.   MAGNETIC RESONANCE IN MEDICINE

In vivo1H NMR spectroscopy of the human brain at high magnetic fields: Metabolite quantification at 4T vs. 7T

(2009) Ivan Tkáč et al.   MAGNETIC RESONANCE IN MEDICINE

Association of common copy number variants at the glutathione S-transferase genes and rare novel genomic changes with schizophrenia

(2009) B Rodríguez-Santiago et al.   MOLECULAR PSYCHIATRY

Neurocognition in first-episode schizophrenia: A meta-analytic review.

(2009) Raquelle I. Mesholam-Gately et al.   NEUROPSYCHOLOGY

The MATRICS Consensus Cognitive Battery, Part 2: Co-Norming and Standardization

(2008) Robert S. Kern et al.   AMERICAN JOURNAL OF PSYCHIATRY

The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity

(2008) Keith H. Nuechterlein et al.   AMERICAN JOURNAL OF PSYCHIATRY

N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial

(2008) Michael Berk et al.   BIOLOGICAL PSYCHIATRY

Negative Correlation between Brain Glutathione Level and Negative Symptoms in Schizophrenia: A 3T 1H-MRS Study

(2008) Daisuke Matsuzawa et al.   PLoS One

Schizophrenia, “Just the Facts” What we know in 2008. 2. Epidemiology and etiology

(2008) R TANDON et al.   SCHIZOPHRENIA RESEARCH